Colorectal Cancer Metastatic Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
Colorectal Cancer Metastatic
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT06540326
Recruiting
Phase 3
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
Colorectal Cancer MetastaticColorectal Cancer Recurrent
Second Affiliated Hospital, School of Medicine, Zhejiang University302 enrolled1 locationNCT06992648
Recruiting
Phase 1Phase 2
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
Colorectal Cancer Metastatic
Wangxia LV26 enrolled1 locationNCT06379399
Recruiting
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
Colorectal Cancer Metastatic
Second Affiliated Hospital, School of Medicine, Zhejiang University125 enrolled1 locationNCT05501353